Logo

FDA Says Ozempic Is No Longer in Shortage—Does That Mean the End of Cheaper Copycat Versions?

FDA Says Ozempic Is No Longer in Shortage—Does That Mean the End of Cheaper Copycat Versions?

Depending on the decision of a pending lawsuit, consumer may soon need to switch from compounded GLP-1s to the name-brand drugs, which are often more expensive.

👉 Full Story